BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bruce MG, Bruden DL, McMahon BJ, Hennessy TW, Reasonover A, Morris J, Hurlburt DA, Peters H, Sacco F, Martinez P, Swenson M, Berg DE, Parks D, Parkinson AJ. Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003. Helicobacter 2006;11:581-8. [PMID: 17083381 DOI: 10.1111/j.1523-5378.2006.00462.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Vakil N, Megraud F. Eradication Therapy for Helicobacter pylori. Gastroenterology 2007;133:985-1001. [DOI: 10.1053/j.gastro.2007.07.008] [Cited by in Crossref: 154] [Cited by in F6Publishing: 151] [Article Influence: 10.3] [Reference Citation Analysis]
2 Bott AM, Bruce MG, Bulkow L, Coleman J, Hennessy TW. Trends in antimicrobial prescribing rates for Alaska Native and American Indian persons <18 years of age residing in the Anchorage region. Int J Circumpolar Health 2009;68:337-46. [PMID: 19917186 DOI: 10.3402/ijch.v68i4.17363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ahmad N, Zakaria WR, Mohamed R. Analysis of antibiotic susceptibility patterns of Helicobacter pylori isolates from Malaysia. Helicobacter. 2011;16:47-51. [PMID: 21241412 DOI: 10.1111/j.1523-5378.2010.00816.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
4 Prazeres VFV, Tizón L, Otero JM, Guardado-calvo P, Llamas-saiz AL, van Raaij MJ, Castedo L, Lamb H, Hawkins AR, González-bello C. Synthesis and Biological Evaluation of New Nanomolar Competitive Inhibitors of Helicobacter pylori Type II Dehydroquinase. Structural Details of the Role of the Aromatic Moieties with Essential Residues. J Med Chem 2010;53:191-200. [DOI: 10.1021/jm9010466] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
5 Garrido L, Toledo H. Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene. Helicobacter. 2007;12:505-509. [PMID: 17760718 DOI: 10.1111/j.1523-5378.2007.00506.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
6 Bruce M, Zulz T, Koch A. Surveillance of infectious diseases in the Arctic. Public Health 2016;137:5-12. [PMID: 27473191 DOI: 10.1016/j.puhe.2016.06.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
7 Kouitcheu Mabeku LB, Eyoum Bille B, Tepap Zemnou C, Tali Nguefack LD, Leundji H. Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates. BMC Infect Dis. 2019;19:880. [PMID: 31640588 DOI: 10.1186/s12879-019-4536-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Khashei R, Dara M, Bazargani A, Bagheri Lankarani K, Taghavi A, Moeini M, Dehghani B, Sohrabi M. High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates. APMIS. 2016; Jun. 30 [Epub ahead of print]. [PMID: 27357065 DOI: 10.1111/apm.12567] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
9 Leja M, Axon A, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter 2016;21 Suppl 1:3-7. [PMID: 27531531 DOI: 10.1111/hel.12332] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
10 Park JY, Dunbar KB, Mitui M, Arnold CA, Lam-Himlin DM, Valasek MA, Thung I, Okwara C, Coss E, Cryer B, Doern CD. Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA. Dig Dis Sci 2016;61:2373-80. [PMID: 26923948 DOI: 10.1007/s10620-016-4091-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
11 Parkinson A, Koch A, Evengård B. Infectious Disease in the Arctic: A Panorama in Transition. In: Evengård B, Nymand Larsen J, Paasche Ø, editors. The New Arctic. Cham: Springer International Publishing; 2015. pp. 239-57. [DOI: 10.1007/978-3-319-17602-4_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
12 Parkinson AJ, Bruce MG, Zulz T. International Circumpolar Surveillance, an Arctic network for the surveillance of infectious diseases. Emerg Infect Dis 2008;14:18-24. [PMID: 18258072 DOI: 10.3201/eid1401.070717] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
13 Hung KH, Sheu BS, Chang WL, Wu HM, Liu CC, Wu JJ. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Helicobacter. 2009;14:61-65. [PMID: 19191898 DOI: 10.1111/j.1523-5378.2009.00655.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
14 Miernyk K, Morris J, Bruden D, McMahon B, Hurlburt D, Sacco F, Parkinson A, Hennessy T, Bruce M. Characterization of Helicobacter pylori cagA and vacA genotypes among Alaskans and their correlation with clinical disease. J Clin Microbiol. 2011;49:3114-3121. [PMID: 21752979 DOI: 10.1128/jcm.00469-11] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
15 Keck JW, Miernyk KM, Bulkow LR, Kelly JJ, McMahon BJ, Sacco F, Hennessy TW, Bruce MG. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study. Can J Gastroenterol Hepatol 2014;28:305-10. [PMID: 24945184 DOI: 10.1155/2014/892084] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
16 Selgrad M, Kandulski A, Malfertheiner P. Helicobacter pylori: diagnosis and treatment. Curr Opin Gastroenterol. 2009;25:549-556. [PMID: 19696666 DOI: 10.1097/mog.0b013e32833159f2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
17 Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43:514-533. [PMID: 26694080 DOI: 10.1111/apt.13497] [Cited by in Crossref: 310] [Cited by in F6Publishing: 288] [Article Influence: 44.3] [Reference Citation Analysis]
18 Mosites E, Bruden D, Morris J, Reasonover A, Rudolph K, Hurlburt D, Hennessy T, McMahon B, Bruce M. Antimicrobial resistance among Helicobacter pylori isolates in Alaska, 2000-2016. J Glob Antimicrob Resist 2018;15:148-53. [PMID: 29969753 DOI: 10.1016/j.jgar.2018.06.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
19 Tveit AH, Bruce MG, Bruden DL, Morris J, Reasonover A, Hurlburt DA, Hennessy TW, McMahon B. Alaska sentinel surveillance study of Helicobacter pylori isolates from Alaska Native persons from 2000 to 2008. J Clin Microbiol. 2011;49:3638-3643. [PMID: 21813726 DOI: 10.1128/jcm.01067-11] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
20 Vakil N. Editorial: H. pylori Treatment: New Wine in Old Bottles? Am J Gastroenterol 2009;104:26-30. [DOI: 10.1038/ajg.2008.91] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
21 Yamamoto T, Takano T, Higuchi W, Nishiyama A, Taneike I, Yoshida K, Kanda H, Imamura Y. Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development. Antimicrob Agents Chemother 2011;55:4261-6. [PMID: 21730117 DOI: 10.1128/AAC.01105-10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
22 Secka O, Berg DE, Antonio M, Corrah T, Tapgun M, Walton R, Thomas V, Galano JJ, Sancho J, Adegbola RA, Thomas JE. Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. Antimicrob Agents Chemother. 2013;57:1231-1237. [PMID: 23263004 DOI: 10.1128/aac.00517-12] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
23 Zheng PX, Fang HY, Yang HB, Tien NY, Wang MC, Wu JJ. Lactobacillus pentosus strain LPS16 produces lactic acid, inhibiting multidrug-resistant Helicobacter pylori. J Microbiol Immunol Infect. 2016;49:168-174. [PMID: 24874430 DOI: 10.1016/j.jmii.2014.04.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
24 Bruden DL, Bruce MG, Miernyk KM, Morris J, Hurlburt D, Hennessy TW, Peters H, Sacco F, Parkinson AJ, McMahon BJ. Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population. World J Gastroenterol 2011; 17(42): 4682-4688 [PMID: 22180710 DOI: 10.3748/wjg.v17.i42.4682] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
25 Wiggins CL, Perdue DG, Henderson JA, Bruce MG, Lanier AP, Kelley JJ, Seals BF, Espey DK. Gastric cancer among American Indians and Alaska Natives in the United States, 1999-2004. Cancer. 2008;113:1225-1233. [PMID: 18720378 DOI: 10.1002/cncr.23732] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
26 Reva I, Takano T, Higuchi W, Iwao Y, Taneike I, Nakagawa S, Ike M, Pererva O, Tarankov A, Agapov M, Rizhkov E, Singur O, Reva G, Potapov V, Yamamoto T. Virulence genotypes and drug resistance of Helicobacter pylori from Vladivostok, Russia: another feature in the Far East: I. Reva et al. Microbiology and Immunology 2012;56:198-202. [DOI: 10.1111/j.1348-0421.2011.00425.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 McMahon BJ, Bruce MG, Koch A, Goodman KJ, Tsukanov V, Mulvad G, Borresen ML, Sacco F, Barrett D, Westby S, Parkinson AJ. The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary. Epidemiol Infect 2016;144:225-33. [PMID: 26094936 DOI: 10.1017/S0950268815001181] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.1] [Reference Citation Analysis]
28 Eisen D. Tetracycline. Kucers' The Use of Antibiotics Sixth Edition. CRC Press; 2010. pp. 843-50. [DOI: 10.1201/b13787-76] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]